JG
PTCT icon

Jain Global’s PTC Therapeutics PTCT Stock Holding History

Jain Global’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,989
Closed -$293K – 1399
2025
Q2 		$293K Sell
5,989
-616
-9% -$29.2K ﹤0.01% 898
2025
Q1 		$337K Sell
6,605
-2
-0% -$100 ﹤0.01% 650
2024
Q4 		$298K Buy
+6,607
New +$283K 0.01% 559

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jain Global's PTCT Position: Q3 2025 in Review

Jain Global sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 5,989 shares — an estimated $293K sold.

Jain Global first reported a position in PTCT in Q4 2024 and held it in 3 quarters. The position peaked at $337K in Q1 2025. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • Jain Global reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 5,989 PTC Therapeutics shares in Q3 2025, an estimated $293K.
  • Jain Global first reported a position in PTC Therapeutics in Q4 2024 and held it in 3 quarters.
  • Jain Global's PTC Therapeutics position peaked at $337K in Q1 2025.
  • 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.